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RESUM
Des de fa ja molt temps, se sap que els estrògens tenen un paper molt important en la repro-
ducció femenina, i hi ha ja també una forta evidència que poden també estar implicats en la
regulació reproductiva masculina. En els humans, en diversos països i durant els darrers cin-
quanta anys, s’ha observat una disminució considerable en el recompte d’espermatozoides i
un augment en la incidència de càncers testiculars, criptorquídies i hipospàdies. En les espècies
salvatges, també s’han observat canvis semblants en la vida reproductiva dels mascles. Aquests
desordres reproductius han estat atribuïts als xenobiòtics i, particularment, als xenoestrògens
que, darrerament, han augmentat progressivament en diversitat i concentració en l’entorn i en
el menjar. Estudis epidemiològics, clínics i experimentals han suggerit que l’exposició excessi-
va als estrògens i als xenoestrògens durant la vida fetal i neonatal podrien conduir a desordres
reproductius en la vida adulta. En aquesta revisió presentem, en un model in vitro, que els es-
trògens afecten directament el desenvolupament del testicle fetal. També demostrem clarament
que els testicles fetals i neonatals són molt sensibles als estrògens, ja que el silenciament del re-
ceptor d’estrògens alfa comporta un augment de l’esteroïdogènesi, i el silenciament del receptor
d’estrògens beta facilita el desenvolupament de la línia cell. ular germinal en el mascle.Paraules clau: estrògens, entorn, testicle, desenvolupament, fetus.
SUMMARY
Estrogens play a major role in female reproduction, but there is now compelling evidence that
they may also be involved in the regulation of the male reproductive function. In humans, a de-
crease in sperm count and an increase in the incidences of testicular cancer, cryptorchidism and
hypospadias, have been observed in many countries in the last fifty years. Changes in the male
reproductive function have also been observed in wildlife. These male reproductive disorders
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have been attributed to xenobiotics, and particularly to xenoestrogens, which have steadily in-
creased in diversity and concentration in the environment and in food. Epidemiological, clinical
and experimental studies have suggested that excessive exposure to estrogens and xenoestro-
gen during fetal/neonatal life can lead to reproductive disorders in adulthood. We showed, in
an in vitro model, that estrogens directly affected the development of the fetal testis. We also
clearly demonstrated that fetal and neonatal testes were very sensitive to estrogens, as the inval-
idation of the estrogen receptor alpha led to an increase in steroidogenesis, and the invalidation
of the estrogen receptor beta enhanced development of the germ cell lineage in the male.Keywords: estrogens, environment, testis, development, fetus.
Concerns about environmental changes
and their possible effects on reproduction in
humans and animals have increased consid-
erably over the last few decades.
CHANGES IN THE MALE
REPRODUCTIVE FUNCTION
In the last few decades, we have observed
an increase in the various abnormalities af-
fecting the reproductive capacities of certain
aquatic species and a qualitative and quan-
titative decrease in human sperm produc-
tion. Furthermore, the incidence of testicu-
lar cancer (the most frequent cancer affecting
young men) has increased steadily over the
last twenty years, in all of the countries where
studies have been made. The incidence of sev-
eral other disorders affecting the male geni-
tal tract also seems to be increasing. This is
the case with cryptorchidism (in which the
testes do not descend into the scrotum), which
is observed in 2 to 4% of neonates, and hy-
pospadias (the ectopic opening of the ure-
thra), which affects 0.3 to 0.7% of boys at birth
(see figure 1).
Various lines of evidence suggest that these
abnormalities could be linked. For exam-
ple, a comparative study in various Euro-
pean countries showed that the incidence
of each of these four types of abnormality
(changes in sperm quality, testicular cancer,
cryptorchidism and hypospadias) is highest
in Denmark and lowest in Finland. It has
also been clearly demonstrated that cryp-
torchidism is a risk factor for the other
three abnormalities and that hypospadias and
oligospermia are risk factors for testicular can-
cer. Finally, men who go on to develop testic-
ular cancer tend to be less fertile. Thus, these
four abnormalities may be seen as different
symptoms of the same syndrome: testicular
dysgenesis syndrome (TDS).
ARE THESE CHANGES DUE
TO THE DISRUPTION
OF TESTICULAR DEVELOPMENT
IN THE FETUS?
The testes begin to carry out their two ma-
jor functions (gametogenesis and steroidoge-
nesis) during fetal development. The Sertoli
cells are the first cells to differentiate. They
surround the germ cells, also known as gono-
cytes, to form the seminiferous tubules 12
days post-conception (dpc) in mice, 13.5 dpc
in rats, and 42 to 45 dpc in humans. The Sertoli
cells continue to actively multiply until pu-
berty, but no further Sertoli cell proliferation
is observed during the rest of a man’s life. The
germ cells are formed in the epiblast and mi-
grate across the extra-embryonic and embry-
onic territories to the genital crests. The germ
cells actively proliferate during this migration
and after reaching the gonad. They then dif-
ferentiate into A spermatogonia (also known
as spermatogonial stem cells) after birth. The
fetal Leydig cells differentiate shortly after the
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Figure 1: Evolution of the number of spermatozoa and of abnormalities of male 
reproductive system throughout the last years. D’après Toppari et al., 2001 (référence 3) et Sharpe 
et Irvine 2004 (référence 2)
Figure 1. The evolution of the number of spermatozoa and of the abnormalities in the male repro-
ductive system in recent years. (Toppari et al., 2001; Sharpe and Irvine, 2004.)
Sertoli cells and secrete two hormones, es-
sential for the masculinization of the fetus:
testosterone and insulin-like factor 3 (Insl3).
It is currently believed that TDS is probably
caused by changes in the development of the
fetal testis (see figure 2) for the following rea-
sons:
— Hypospadias results from a defect in the
production or activity of androgens during fe-
tal development.
— Cryptorchidism results from abnormal-
ities in the production or activity of Insl3 or
the androgens regulating the transabdominal
and transinguinal descent, respectively, of the
testes.
— Although the cellular origin of testicular
cancer has not been demonstrated, there is ev-
idence to suggest that the tumor cells originate
from gonocytes that fail to differentiate nor-
mally into spermatogonia. Indeed, tumor cells
in the early stages of this cancer (carcinoma in
situ, CIS) have the same morphological char-
acteristics and express the same immunohis-
tochemical markers as gonocytes (e.g., alka-
line phosphatase, c-kit, etc.). Furthermore, CIS
has been reported in male infants, only a few
months old, consistent with the idea of a fetal
origin for the cancerous cells.
— Finally, decreases in sperm production in
male adults may result from a wide variety of
dysfunctions. Little is known about the con-
trol of spermatogenesis, but this control seems
to involve extraordinarily complex intratestic-
ular and intragerminal endocrine regulation.
We know that the stock of gonocytes will go
on to become spermatogonial stem cells in the
adult forms during fetal testicular develop-
ment. Experimentally decreasing the number
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Figure 2 : Schematic representation of the fetal origin of the alterations of male 
reproductive functions. 
From Skakkebaeck et al., 2001 (référence 5) 
Figure 2. A schematic representation of the fetal origin of alterations in male reproductive func-
tions. (Skakkebaek et al., 2001.)
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Figure 3 : Histological aspect of the mouse neonatal testis observed 2 days after birth. 
A: Seminiferous cord after coloration by Tushmann’s blue. Arrows indicate the gonocytes which are 
identified by their large, spherical, lightly stained nuclei containing fine chromatin granules and two or 
more globular nucleoli and by a clearly visible cytoplasmic membrane. Arrowheads indicate the Sertoli 
cells characterized by their irregular densely stained nucleus located in basal position in the seminiferous 
cord and by no clear cytoplasmic membrane.. B: Leydig cells, located in intertitial compartment stained by 
immunohistochemical labeling of 3ß-hydroxysteroid dehydrogenase (3ßHSD) are often grouped in clusters 
at this developmental stage.
Figure 3. A histological aspect of the mouse neonatal testis
observed 2 days after birth. a) A seminiferous cord after col-
oration using Tushmann’s blue. Arrows indicate the gonocytes,
which are identified by th ir large, spherical, lightly-stai ed nu-
cle , contai ing fine chromatin granules and two or more globular
nucleoli and by a clearly visible cytoplasmic membrane. Arrow-
heads indicate the Sertoli cells, characterized by their irregular
and densely-stained nucleus, located at the basal position in the
seminiferous cord and by no clear cytoplasmic membrane. b)
Leydig cells, located in the intertitial compartment, stained by
immunohistochemical labeling of 3β-hydroxysteroid dehydroge-
nase (3βHSD), are often grouped in clusters at this developmental
stage.
of gonocytes during fetal development leads
to a decrease in sperm production in the adult.
Similar decreases in adult sperm production
result from the experimental reduction of the
number of Sertoli cells during the perina-
tal period. Thus, adult sperm production de-
pends partly on fetal gametogenesis and on
the capacity of gonocytes to differentiate into
spermatogonial stem cells.
THE DELETERIOUS EFFECTS
OF XENOESTROGENS
Sharpe and Skakkebaek suggested in 1993
that the reported problems in the domain
of the male reproductive function could be
due to the deleterious effects on the develop-
ing fetus of chemical pollutants, which have
steadily increased in diversity and concen-
tration in the environment. Many observa-
tions and experiments, over the course of the
last twenty years, are consistent with this hy-
pothesis. The principal chemical pollutants
implicated in these effects are endocrine dis-
rupters with estrogenic (xenoestrogens) or
anti-androgenic activity. These compounds
include pesticides, plastifying agents, surfac-
tants and phytoestrogens, present in food and,
to some extent, the atmosphere.
Studies of wildlife have provided evidence
for the involvement of endocrine disrupters
in the deterioration of the male reproductive
function. A number of publications have re-
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ported the effects of exposure to high con-
centrations of chemical pollutants with estro-
genic properties on animals in their natural
environment. The observed effects vary from
subtle changes to permanent changes in the
reproductive function, such as feminization or
changes in sexual behavior.
A key, clinical argument concerns the ab-
normalities observed in the sons of women
treated with diethylstilbestrol (DES), a strong
estrogen agonist, during pregnancy in the
1950s, 60s and 70s. Some studies have shown
that those men have a high incidence of
genital malformations, cryptorchidism and
testicular cancers, together with changes in
sperm quality, whereas others have reported
no change in fertility. These discrepancies in
the results may depend on the phase of the
pregnancy in which the treatment was given,
suggesting that there could be particular pe-
riods of time, when the developing testis is
more sensitive to xenoestrogens.
Another clinical argument concerns the re-
cent demonstration of the negative effects of
phthalates (plastifiers found in cosmetics, al-
most all PVC products, and many paints) on
the development of the male reproductive ap-
paratus. There is a correlation between the
level of exposure (estimated by measuring
the phthalates concentration in the urine of
pregnant women) and the lower levels of mas-
culinization in young children (a decrease in
the distance between the anus and the base
of the penis and an increase in the percent-
age of boys showing incomplete descent of the
testes).
There is also a considerable body of ex-
perimental evidence. First, estrogen receptors
(ERα and ERβ) are present in the testis from
the earliest stages of differentiation. ERα has
been detected in the undifferentiated gonads
in mice from 10 dpc onwards. This receptor
is present in Leydig cells in rodent testes but
is not present in human testes. ERβ has been
detected in the testes of mice, from 14 dpc
onwards. It is found primarily in the gono-
cytes, but also in the Leydig cells in mice
and in the Sertoli cells of all of the species
studied. Many studies have shown that, in
rodents, males exposed to exogenous estro-
gens (e.g., DES, ethynylestradiol, bisphenol
A), in utero or during neonatal development,
develop hypospadias, display impaired tes-
ticular descent, or show a decrease in sperm
production. Similarly, exposure to high doses
of estrogens in utero has been shown to lead
to testicular cancer in mice, rats, hamsters and
dogs in adulthood.
ENDOGENOUS ESTROGENS
AND FETAL/NEONATAL
TESTIS DEVELOPMENT
Although exogenous estrogens were sus-
pected of having a deleterious effect on testic-
ular development, in the recent past little was
known about the effects of endogenous estro-
gens.
Studies on male mice with invalidated re-
ceptors for estrogens (ERαKO or ERβKO) or
aromatase (ArKO), an analysis of patients
lacking aromatase, and another study on an
individual with an ERα mutation have shown
that the absence of estrogens or of certain es-
trogen signaling pathways may also impair
the reproductive capacity. Adult ERαKO and
ArKO males are sterile, due to deficiencies
in fluid reabsorption in the epididymis in
ERαKO mice and abnormal spermatogenesis
in ArKO mice. It has, therefore, been clearly
shown that estrogens are required for male re-
productive functions in the adult.
However, none of these studies provided
information about the role of estrogens on fe-
tal development. We recently studied the fetal
and neonatal development of the testis (see
figure 3) in ERαKO and ERβKO mice. We
showed that the invalidation of ERβ led to a
50% increase in the number of gonocytes two
days post- partum (dpp) (see figure 4) and
which was still observed at 6 dpp. This re-
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Figure 4 : Evolution of the number of gonocytes in the mouse testis during fetal and neonatal 
stages after ERß or ERα gene inactivation.  Proliferation and quiescient periods of the gonocytes 
throughout the considerd developmental period are indicated. Gonocytes on histological testis 
sections from 13.5 dpc, 15.5 dpc, 17.5 dpc and 2 dpp animals were counted. Values are means ± 
SEM of 4 to 13 animals. *** : P<0.001 versus wild type in t test’s Student. From Delbes et al 2004 
(reference 20).
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Figure 4. The evolution of the number of gonocytes in the mouse testis during fetal and neona-
tal stages after ERβ or ER gene deactivation. Proliferation and quiescent periods of the gonocytes,
throughout the considered developmental period, are indicated. Gonocytes on histological testis sec-
tions from 13.5 dpc, 15.5 dpc, 17.5 dpc and 2 dpp animals were counted. Values are means ± SEM of
4 to 13 animals. ***: P < 0.001 versus wild-type in t test’s Student. (Delbes et al., 2004.)
sulted from an increase in the mitotic activity
of these cells and a decrease in their apop-
totic activity, with no change in the number
of Sertoli cells. Conversely, the invalidation of
ERα did not affect the number of germ or Ser-
toli cells, but it did increase testosterone pro-
duction (see figure 5). This increase in testos-
terone production was observed from 13 dpc
onwards. Thus, it began less than two days
after the first Leydig cells differentiated and
resulted from direct estrogenic action on the
testis. There were no changes in the luteiniz-
ing hormone (LH) secretion, whereas changes
in LH concentration seemed to play a key
role in the case of the ERαKO adults. The ac-
tivity of each fetal Leydig cell increased, as
shown by the hypertrophy of these cells and
the increase in the mRNA levels for three pro-
teins involved in testosterone synthesis (StAR,
P450scc and P450c17). In contrast, the invali-
dation of ERβ had no effect on fetal testicular
steroidogenesis (see figure 5).
We have thus shown that, in contrast to
what is observed in adults, endogenous es-
trogens have a negative effect on the func-
tions and development of the testis during
fetal and neonatal life. Each of the estrogen
receptors plays a distinct role in testicular de-
velopment, with ERβ being involved in the
regulation of germ cell development and ERα
being involved in the regulation of Leydig cell
development and function.
Over the last few years, we have developed
an organotypic culture system for rat fetal and
neonatal testes, which can reproduce the de-
velopment in vitro of the various types of testis
cells observed in vivo. Using this model in a
collaborative study, we have shown that es-
trogens have a direct, negative effect on the
development of the three principal cell types.
Studies on the ontogenesis of estrogen effects
in vitro during fetal and neonatal develop-
ment are currently under investigation in our
lab, and the first results have demonstrated
that there are periods in which the testes are
particularly sensitive to estrogens.
UNANSWERED QUESTIONS
The available experimental data suggest
that the irreversible deleterious effects of es-
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Figure 5 : Production of testosterone by the fetal and neonatal mouse testis after ERß or 
ERα gene inactivation. Testes were collected on day 13.5 (13.5 dpc) of gestation and on 
postnatal day 2 (2 dpp) and cultured on floating Millipore filters for 3 h in the présence (+LH) 
or the absence (basal) of 100ng/ml ovine LH. The testosterone secreted in the medium was 
measured by RIA. Values are means ± SEM of 7 to 19 fetuses. ** : p<0,01 and *** : p<0.001 
versus wild type in t test’s Student. From Delbes et al 2005 (reference 21).
Figure 5. The production of testosterone by the fetal and neonatal mouse testis after ERβ or ER
gene deactivation. Testes were collected on day 13.5 (13.5 dpc) of gestation and on post-natal day
2 (2 dpp) and were cultured on floating Millipore filters for 3 h in the presence (+LH) or the absence
(basal) of 100 ng/ml ovine LH. The testosterone secreted in the medium was measured by RIA. Values
are means ± SEM of 7 to 19 fetuses. **: p < 0.01 and ***: p < 0.001 versus wild-type in t test’s Student.
(Delbes et al., 2005.)
trogens on testicular development and the
masculinization of the genital tract occur dur-
ing fetal and neonatal development. We have
shown that endogenous estrogens regulate
the physiological development of the testis
during fetal and neonatal life, by controlling
the two principal functions of the fetal and
neonatal testis: gametogenesis and steroido-
genesis. We have seen that dysfunctions in
the establishment of the germ cell lineage are
likely to induce testicular cancers and to lead
to changes in sperm production. Estrogens
also control the secretion of testosterone and,
therefore, play an important role in the mas-
culinization of the genital tract and the de-
scent of the testicles.
However, the link between the effects ob-
served at birth and their consequences for
adult fertility remains unclear, particularly
as many of the mechanisms regulating sper-
matogenesis do not become operational until
puberty. Thus, deficiencies in estrogen path-
ways have positive effects on the fetus and
neonate, but they have negative effects on
adults. It would be advisable to develop mice
strains with conditional gene knockouts, func-
tioning only during fetal development; this
would be helpful in demonstrating that the
abnormalities induced by the absence of estro-
gens or estrogens signaling, restricted to fetal
and neonatal life, have consequences on the
adult.
There seem to be periods during fetal and
neonatal development, when the testes are
particularly sensitive to estrogens, and this
estrogen sensitivity depends on the species
and the strain considered. It is, therefore, par-
ticularly important to study the sensitivity
of the human fetal testes, as, unlike rodent
testes, human testes do not contain ERα but
do contain multiple variants of ERβ.
Finally, all of the available experimental
data demonstrate the deleterious effects of
high doses of xenoestrogens, and some show
that exposure to low doses has no irreversible
deleterious effects. It, therefore, remains un-
clear whether increases in the xenoestrogen
levels in the environment have a direct ef-
fect on the human male reproductive function,
and some studies have suggested that the con-
centrations of endocrine disrupters reached in
the body are too low for xenohormonal ef-
fects to be observed. However, the lipophilic
nature of these compounds may lead to their
accumulation, and their effects may be ampli-
fied by the combined consequences of diverse
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xenoestrogens. The growing body of epidemi-
ological and experimental evidence, linking
the actions of estrogens with the male repro-
ductive function, may justify medical and en-
vironmental preventive measures.
Lastly, a very recent study has highlighted
the importance of this problem by demon-
strating that rats descended from a great-
grandfather, exposed to high levels of en-
docrine disrupters during fetal development,
have low levels of sperm production. Thus,
changes in fetal testis development are ob-
served, not only in the contaminated individ-
ual during adulthood, but they are also trans-
mitted to subsequent generations through an
as yet undetermined mechanism.
FOOTNOTE BY RENÉ HABERT
This paper is dedicated to my mentor, José
Maria Sáez, who became a very close friend.
The members of my laboratory, who also
collaborated with him and wanted to honor
his memory, have signed their names to this
work. The choice of a topic for this review, in
relation to the work of José M. Sáez, was an
easy task, so intense were his scientific ideas
and production. This paper, which deals with
the actions of estrogens on the fetal testis, is
in direct connection with the fact that José
M. Sáez assumed very early on that estrogens
played an important and direct role in testic-
ular regulation. As early as 1978, he wrote,
“it is apparent from the present study that
oestradiol, at the doses used, produces a low-
ering effect on testosterone levels via a direct
action at the testicular level, rather than an
indirect action on the hypothalamic-pituitary
axis”; Acta endocrinologica, 89: 379-392.
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